INTRODUCTION
Since the beginning of the acquired immunodeficiency syndrome (AIDS) epi demic in the early 1980s through December 1999, 733,374 cases of AIDS have been reported to the Centers for Disease Control and Prevention (Centers for Disease Control and Prevention, 1999) . Providing for the care for persons living with AIDS presents a remarkable burden to both public and private insurers. Holtgrave and Pinkerton, 1997 estimated that lifetime costs for treatment per patient after the advent of protease inhibitors ranged from $71,143 to $424,763 with the difference primarily based on access to care and whether the real costs were dis counted.
The author is with the Center for Medicaid and State Operations, Health Care Financing Administration (HCFA). The views expressed in this article are those of the author and do not nec essarily reflect the views of HCFA.
HCFA'S ROLE IN FINANCING CARE
The Medicaid program is the largest payer in the United States for medical ser vices provided to persons living with AIDS. HCFA estimates that Medicaid pays for the care of 50 percent of all persons living in the United States with AIDS and for 90 percent of the children living with AIDS. (Health Care Financing Administration, 2000a) Medicaid pays for medical and remedial services for individuals with low incomes who are either members of families with children, over the age of 65, disabled, or blind. Other optional categories of eligible persons may be covered at a State's choice (Federal Register, 1999) . Most persons with AIDS are eligible for Medicaid because their disease has progressed to the point that they meet the Social Security Administration's definition of disability, e.g., the person is no longer able to partici pate in gainful activity due complications of the disease. Gainful activity is defined as being able to earn at least $700 per month.
HCFA's estimates indicate that the Medicaid program was paying for the care of 5,300 persons living with AIDS in 1986 (Health Care Financing Administration, 1990 . Federal and State Medicaid expendi tures were estimated in the same document to be $220 million dollars for Federal fiscal year (FFY) 1986. Today, HCFA estimates that the Medicaid program will pay for the services provided to 114,000 persons living 
Medicaid Coverage of Prescription Drugs
Although coverage of prescription drugs is not required, all States and the District of Columbia currently cover prescription drugs under their Medicaid programs. However, some States do limit the number of prescrip tion drugs that may be filled in a month and/or the number of refills permitted.
HCFA gave clear direction to State Medicaid agencies in a letter dated June 19, 1996 , that States which elect to cover pre scription drugs are required to cover all the FDA-approved PIs, and other FDAapproved drugs. Most combination anti retroviral regimens cost between $12,000 and $15,000 per patient per year, however, with many patients being placed on regi mens of four and five drugs, the cost can grow significantly. Figure 2 shows the increase in Medicaid expenditures for HIV antiretroviral drugs from the last quarter of FY 1996 (July, August, and September) and the last quarter of FY 1999 (Health Care Financing Administration, 2000b) .
QUALITY OF CARE PROVIDED MEDICAID BENEFICIARIES
States have made efforts to improve the quality of care for Medicaid beneficiaries with AIDS by widely distributing treatment guidelines provided by HCFA, and encour aging providers to take advantage of treat ment resources provided on the internet. Some States have been aggressive in devel oping Medicaid waivers that provide ser vices essential to the improvement of the care and quality of life for persons with AIDS. Currently 16 States have home and community-based services waivers that provide services specifically to persons with AIDS; these services are necessary to avoid or minimize costly hospital or nurs ing facility stays. Services provided may include case management, homemaker services, home health care services, adult day health care, basic living skills and voca tional training, and respite care.
Despite States' efforts to improve the quality of care and the broad package of ser vices that are available to Medicaid benefi ciaries with AIDS, early studies indicated that the quality of care being provided to Medicaid beneficiaries is less than optimal. The HIV Cost and Services Utilization Study, a national sample representative of the adult HIV-infected population receiving regular medical care in the 48 contiguous States from early 1996 to early 1998, found disparities between the quality of care pro vided to Medicaid beneficiaries and persons having other types of insurance coverage. The study measured quality using six mea sures: (1) fewer than two office or outpa tient visits in 6 months, (2) emergency department visit without an associated hos pitalization in 6 months, (3) hospitalization in 6 months, (4) did not receive PI or NNRTI therapy by December 31, 1996 if recommendations for treatment were met, (5) never received antiretroviral treatment, and (6) did not receive prophylaxis in the last 6 months for pneumocystis carinii, a type of pneumonia to which persons with AIDS are susceptible, if CD4 count was less than 200. (CD4 count is a measure of the health of the immune system. Mean levels in healthy individuals are usually between 800-1050.) Data gathered for the base line of the study showed that Medicaid benefi ciaries faired worse on all six measures than did persons with private insurance, and worse on four of the measures than Medicare beneficiaries. Not surprisingly, Medicare beneficiaries had more emer gency department visits and more hospital izations. Overall, the only group that received poorer care than Medicaid benefi ciaries were those without any insurance.
However, States' efforts to improve qual ity are showing results. Encouragingly in the followup interviews conducted in 1998, Medicaid showed improvement in the quality of care provided as measured in all six of the indicators of quality of care. Most notable was the increase in the use of PIs and NNRTIs which rose from 53 per cent to 81 percent (Shapiro et al., 1999) .
CHANGING DEMOGRAPHICS OF HIV DISEASE
Over time, the demographic characteris tics of the HIV epidemic have changed, as has the natural history of HIV infection among persons receiving appropriate treatment. HIV/AIDS in the developed world has been transformed from a rapidly fatal infection diagnosed at a late stage of the disease to a chronic progressive illness that affords many years of productive life under complex treat ment regimens (Department of Health and Human Services, 2000a) . With this change in the natural history of the disease, the cate gorical nature of the Medicaid program has rendered many persons receiving proper treatment unable to qualify for Medicaid because they don't meet the definition of dis ability. The majority of these individuals who are uninsured receive their care through the Ryan White CARE Act programs which base eligibility on HIV positive status. As persons with HIV disease live longer, the demands on Ryan White funding have increased.
Medicaid's Response to the Changing Demographics
To address the issue of the Medicaid program not being able to serve persons with chronic manageable diseases, a num ber of actions have taken place at both the Federal and State levels.
• The State of Maine has submitted and gained HCFA approval for a demonstra tion waiver that permits Medicaid cover age to be extended to persons with HIV disease prior to becoming disabled. The theory of the demonstration is that early treatment will delay the onset of AIDS and thus offset the cost of the early treat ment making the demonstration budget neutral to the Medicaid program. A num ber of other States are also pursuing sim ilar waiver authority. 
CONCLUSION
The Medicaid program is the largest payer of health care services for persons living with AIDS in the United States. Although questions have been raised about the quality of care being provided to Medicaid beneficiaries with HIV disease, more recent studies reflect a significant improvement in quality of care as mea sured by the indicators used in the study. State Medicaid agencies are working with HCFA to continue the trend in improving care to persons with HIV disease. HCFA will continue to work with States and other Federal agencies to improve the delivery of services to persons with HIV disease in the most effective manner. HCFA is also working with States to implement new pro grams designed to address the chronic care needs of persons with AIDS who are benefiting from new, more effective treat ment regimens.
HCFA has a particular interest in pre vention of childhood AIDS, as the payer of care for 90 percent of the children with AIDS. With the majority of childhood AIDS due to mother-to-child HIV transmis sion, HCFA is taking a leadership role in prevention of childhood AIDS by establish ing and promoting its Maternal HIV Consumer Information Program.
